Developer of novel therapeutics, Ophthotech Corp (NASDAQ:OPHT) announced that it has struck a deal with the German-based Novartis AG (ADR) (NYSE:NVS), on licensing and commercialization of drug, Fovista, outside the U.S. Novartis AG (ADR) (NYSE:NVS), net profit margin is 16.50% and weekly performance is 0.69%. On last trading day company shares ended up $89.08. Analysts mean target price for the company is $87.94. Novartis AG (ADR) (NYSE:NVS), distance from 50-day simple moving average (SMA50) is 5.12%.
Sanofi SA (ADR) (NYSE:SNY), saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 2,473,522 shares, a drop of 43.8% from the March 31st total of 4,402,961 shares, Stock Ratings News reports. Based on an average daily trading volume, of 2,245,371 shares, the days-to-cover ratio is presently 1.1 days. Approximately 0.0% of the company’s shares are sold short. Sanofi SA (ADR) (NYSE:SNY), fell 0.83% in last trading session and ended the day on $52.56. SNY, Gross Margin is 67.20% and its return on assets is 3.10%. Sanofi SA (ADR) (NYSE:SNY), quarterly performance is 8.04%.
Pfizer Inc. (NYSE:PFE), may have called its $118 billion bid for AstraZeneca Plc a “final” offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn’t ready to call in the undertakers. Pfizer Inc. (NYSE:PFE), shares moved down 0.10% in last trading session and was closed at $29.25, while trading in range of $29.21 – 29.54. Pfizer Inc. (NYSE:PFE), year to date (YTD) performance is -2.86%.
GlaxoSmithKline plc (ADR) (NYSE:GSK), announced that it will freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance support. By committing to offer GAVI Alliance prices for vaccines against pneumococcal disease, rotavirus and cervical cancer, GSK will support developing country governments as they transition to financing the full cost of their local vaccination programmes. GlaxoSmithKline plc (ADR) (NYSE:GSK), ended the last trading day at $54.71. Company weekly volatility is calculated as 0.83% and price to cash ratio as 21.95. GlaxoSmithKline plc (ADR) (NYSE:GSK), showed a negative weekly performance of -0.31%.
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), announced the establishment of a strategic alliance with Pathology, Inc. in Torrance, Calif., that designates the company as a Roche Molecular Center of Excellence (MCOE) for the next five years. Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), on last trading day company shares ended up $37.24.
Leave a Reply